214 related articles for article (PubMed ID: 29901078)
1. Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db/db mice.
Liu Y; Song A; Yang X; Zhen Y; Chen W; Yang L; Wang C; Ma H
Int J Mol Med; 2018 Sep; 42(3):1723-1731. PubMed ID: 29901078
[TBL] [Abstract][Full Text] [Related]
2. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
3. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of farnesoid X receptor activation on metabolism in a diabetic rat model.
Zhang HM; Wang X; Wu ZH; Liu HL; Chen W; Zhang ZZ; Chen D; Zeng TS
Mol Med Rep; 2016 Mar; 13(3):2135-42. PubMed ID: 26782298
[TBL] [Abstract][Full Text] [Related]
5. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
6. Grape seed procyanidin B2 ameliorates hepatic lipid metabolism disorders in db/db mice.
Yin M; Zhang P; Yu F; Zhang Z; Cai Q; Lu W; Li B; Qin W; Cheng M; Wang H; Gao H
Mol Med Rep; 2017 Sep; 16(3):2844-2850. PubMed ID: 28677803
[TBL] [Abstract][Full Text] [Related]
7. Policosanol alleviates hepatic lipid accumulation by regulating bile acids metabolism in C57BL6/mice through AMPK-FXR-TGR5 cross-talk.
Zhai Z; Niu KM; Liu H; Lin C; Tu Y; Liu Y; Cai L; Ouyang K; Liu J
J Food Sci; 2021 Dec; 86(12):5466-5478. PubMed ID: 34730235
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
9. Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice.
Kim KH; Choi S; Zhou Y; Kim EY; Lee JM; Saha PK; Anakk S; Moore DD
Hepatology; 2017 Aug; 66(2):498-509. PubMed ID: 28378930
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
11. Novel ι-Carrageenan Tetrasaccharide Alleviates Liver Lipid Accumulation via the Bile Acid-FXR-SHP/PXR Pathway to Regulate Cholesterol Conversion and Fatty Acid Metabolism in Insulin-Resistant Mice.
Li Y; Tian Y; Cai W; Wang Q; Chang Y; Sun Y; Dong P; Wang J
J Agric Food Chem; 2021 Sep; 69(34):9813-9821. PubMed ID: 34415766
[TBL] [Abstract][Full Text] [Related]
12. Eburicoic Acid, a Triterpenoid Compound from Antrodia camphorata, Displays Antidiabetic and Antihyperlipidemic Effects in Palmitate-Treated C2C12 Myotubes and in High-Fat Diet-Fed Mice.
Lin CH; Kuo YH; Shih CC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099085
[TBL] [Abstract][Full Text] [Related]
13. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity.
Mencarelli A; Cipriani S; Renga B; D'Amore C; Palladino G; Distrutti E; Baldelli F; Fiorucci S
Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):94-101. PubMed ID: 21924881
[TBL] [Abstract][Full Text] [Related]
14. Alisol B 23-acetate protects against non-alcoholic steatohepatitis in mice via farnesoid X receptor activation.
Meng Q; Duan XP; Wang CY; Liu ZH; Sun PY; Huo XK; Sun HJ; Peng JY; Liu KX
Acta Pharmacol Sin; 2017 Jan; 38(1):69-79. PubMed ID: 27773935
[TBL] [Abstract][Full Text] [Related]
15. Oxymatrine attenuates hepatic steatosis in non-alcoholic fatty liver disease rats fed with high fructose diet through inhibition of sterol regulatory element binding transcription factor 1 (Srebf1) and activation of peroxisome proliferator activated receptor alpha (Pparα).
Shi LJ; Shi L; Song GY; Zhang HF; Hu ZJ; Wang C; Zhang DH
Eur J Pharmacol; 2013 Aug; 714(1-3):89-95. PubMed ID: 23791610
[TBL] [Abstract][Full Text] [Related]
16. A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation.
An HJ; Lee B; Kim SM; Kim DH; Chung KW; Ha SG; Park KC; Park YJ; Kim SJ; Yun HY; Chun P; Yu BP; Moon HR; Chung HY
Biol Pharm Bull; 2018; 41(1):29-35. PubMed ID: 29311481
[TBL] [Abstract][Full Text] [Related]
17. Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway.
Xin C; Liu J; Zhang J; Zhu D; Wang H; Xiong L; Lee Y; Ye J; Lian K; Xu C; Zhang L; Wang Q; Liu Y; Tao L
Int J Obes (Lond); 2016 Mar; 40(3):443-51. PubMed ID: 26403433
[TBL] [Abstract][Full Text] [Related]
18. Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model.
Han SY; Song HK; Cha JJ; Han JY; Kang YS; Cha DR
Acta Diabetol; 2021 Apr; 58(4):495-503. PubMed ID: 33399988
[TBL] [Abstract][Full Text] [Related]
19. [Effect of Danlou Tablets on alleviating hepatic adipogenesis, inflammatory response, and insulin resistance in db/db mice].
Pang YF; Huang M; Li L; Zhao X; Zhang HX; Li YH
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3320-3327. PubMed ID: 35851126
[TBL] [Abstract][Full Text] [Related]
20. Synthetic FXR agonist GW4064 prevents diet-induced hepatic steatosis and insulin resistance.
Ma Y; Huang Y; Yan L; Gao M; Liu D
Pharm Res; 2013 May; 30(5):1447-57. PubMed ID: 23371517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]